Special Issue "Multimodality Therapy of Gastrointestinal and Hepatopancreatobiliary Cancers"
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Gastroenterology & Hepatopancreatobiliary Medicine".
Deadline for manuscript submissions: closed (30 June 2020).
Interests: multimodality therapy; neoadjuvant therapy; gastrointestinal and hepatopancreatobiliary cancers; neuroendocrine tumors; surgery; patient-centered outcomes
Gastrointestinal and hepatopancreatobiliary cancers are aggressive malignancies that require multidisciplinary treatment approaches. As novel therapies are regularly introduced, the optimal treatment approaches for these aggressive cancers is becoming increasingly complex. For localized cancers, neoadjuvant and adjuvant approaches are increasingly being applied. For patients with advanced disease, combination regimens and multimodality approaches are being utilized with increasing frequency. However, the indications for and outcomes of multimodality therapy for these cancers require additional research. This Special Issue aims to focus on advances in multimodality therapies for patients with gastrointestinal and hepatopancreatobiliary cancers, including the evaluation of novel treatment regimens, patient-centered outcomes, short-term safety, and long-term efficacy of such treatments.
Dr. Jordan Cloyd
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- pancreatic cancer
- hepatocellular carcinoma
- colon cancer
- gallbladder cancer
- gastric cancer
- esophageal cancer
- neoadjuvant therapy
- adjuvant therapy
- neuroendocrine tumor